Los Angeles
CHANGE MY LOCATION
MATTHEW PERRONE
Stryker pushes back against government inspectors
- In an unusually aggressive move, Stryker Corp. is resisting an ongoing federal investigation into whether the company illegally pushed sales of its replacement knees and hips.
Companies report 4 new deaths with diabetes drug
- Eli Lilly and Amylin Pharmaceuticals Inc. on Tuesday reported four new deaths in patients taking Byetta, even as the companies tried to shore up the safety profile of their popular diabetes medication.
Abbott to cut 1,000 jobs from diagnostic unit
- Drug and medical device maker Abbott Laboratories said Thursday it will cut 1,000 jobs as part of a multiyear effort to lower spending on its medical testing business.
States fight to shield docs from drug data mining
- When most patients go to the pharmacy to fill a new prescription, they don't think twice about turning over the note from their doctor.
Medtronic 1Q profit up on stent, spinal strength
- Medtronic Inc.'s first-quarter earnings beat Wall Street estimates Tuesday on a combination of lower expenses and higher sales of devices to treat clogged arteries, fractured spines and other ailments.
FDA reports deaths with diabetes drug Byetta
- Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. after deaths were reported with the medication despite earlier government warnings.
